help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rouiller-Fabre, V.
Right arrow Articles by Vigier, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rouiller-Fabre, V.
Right arrow Articles by Vigier, B.
Endocrinology Vol. 139, No. 3 1213-1220
Copyright © 1998 by The Endocrine Society

ARTICLES

Effect of Anti-Mullerian Hormone on Sertoli and Leydig Cell Functions in Fetal and Immature Rats1

V. Rouiller-Fabre, S. Carmona, R. Abou Merhi, R. Cate, R. Habert and B. Vigier

Institut National de la Santé et de la Recherche Medicale-Institut National de Recherches Agronomiques U-418, Equipe de Différenciation Cellulaire des Gonades, Université Paris 7 (V.R.-F., R.H.), and URA-CNRS 1449, Laboratoire de Physiologie de la Reproduction, Equipe de Différenciation de la Gonade (S.C., B.V.), 75251 Paris; and Institut National de Recherches Agronomiques, Laboratoire de Biologie Cellulaire et Moléculaire, Bâtiment des Biotechnologies (R.A.M.), 78352 Jouy en Josas, France; and Biogen, Inc. (R.C.), Cambridge, Massachusetts 02142

Address all correspondence and requests for reprints to: Dr. B. Vigier, Unité INRA "Differenciation Cellulaire et Moléculaire" Bâtiment des Biotechnologies, 78352 Jouy en Josas, France.

Anti-Mullerian hormone (AMH) is mainly involved in the regression of Mullerian ducts in male fetuses, but it may have other functions linked to gonadal development. The present study examines the effect of AMH on steroidogenesis by Sertoli and Leydig cells in fetal and immature rats during the period where AMH is physiologically produced in the testis.

The basal aromatase activity of Sertoli cells in primary culture was strongly stimulated (77–91%) by cAMP. AMH (35 nM) reduced cAMP-stimulated aromatase activity by 49–69% as early as fetal day 16 and until postnatal day 20. This effect was dose dependent and was seen after 48 h in culture. AMH also blocked the Sertoli cell aromatase activity stimulated by FSH, but LH did not stimulate this activity, confirming that the aromatase activity effectively resulted from Sertoli cells and not from contaminating Leydig cells. RT-PCR analysis showed that AMH reduced aromatase activity by decreasing the amount of aromatase messenger RNA.

AMH also inhibited the LH-stimulated testosterone production by dispersed fetal Leydig cells in culture in a dose-dependent manner. The inhibitory effect of AMH did not depend on the fetal stage studied (16 or 20 days postconception) and resulted from a drop in the steroidogenic activity of each Leydig cell without affecting the number of 3ß-hydroxysteroid dehydrogenase-positive cells.

These data provide the first evidence that AMH, like other members of the transforming growth factor-ß family, has an autocrine/paracrine effect on testicular steroidogenic function during the fetal and prepubertal periods.




This article has been cited by other articles:


Home page
 Toxicol SciHome page
G. Delbes, C. Duquenne, J. Szenker, J. Taccoen, R. Habert, and C. Levacher
Developmental Changes in Testicular Sensitivity to Estrogens throughout Fetal and Neonatal Life
Toxicol. Sci., September 1, 2007; 99(1): 234 - 243.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
G. Delbes, C. Levacher, and R. Habert
Estrogen effects on fetal and neonatal testicular development.
Reproduction, October 1, 2006; 132(4): 527 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J. S. Tapanainen
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
Hum. Reprod., July 1, 2005; 20(7): 1820 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Wu, R. Arumugam, S. P. Baker, and M. M. Lee
Pubertal and Adult Leydig Cell Function in Mullerian Inhibiting Substance-Deficient Mice
Endocrinology, February 1, 2005; 146(2): 589 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
G. Livera, C. Pairault, R. Lambrot, M. Lelievre-Pegorier, J.M. Saez, R. Habert, and V. Rouiller-Fabre
Retinoid-Sensitive Steps in Steroidogenesis in Fetal and Neonatal Rat Testes: In Vitro and In Vivo Studies
Biol Reprod, June 1, 2004; 70(6): 1814 - 1821.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
H. Zhu, H. Ma, H. Ni, X.-H. Ma, N. Mills, and Z.-M. Yang
Expression and Regulation of Lipocalin-Type Prostaglandin D Synthase in Rat Testis and Epididymis
Biol Reprod, April 1, 2004; 70(4): 1088 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. P. Houk, E. J. Pearson, N. Martinelle, P. K. Donahoe, and J. Teixeira
Feedback Inhibition of Steroidogenic Acute Regulatory Protein Expression in Vitro and in Vivo by Androgens
Endocrinology, March 1, 2004; 145(3): 1269 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Y. Bedecarrats, F. H. O'Neill, E. R. Norwitz, U. B. Kaiser, and J. Teixeira
Regulation of gonadotropin gene expression by Mullerian inhibiting substance
PNAS, August 5, 2003; 100(16): 9348 - 9353.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. Chang, C. W. Brown, and M. M. Matzuk
Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily
Endocr. Rev., December 1, 2002; 23(6): 787 - 823.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
T. Miura, C. Miura, Y. Konda, and K. Yamauchi
Spermatogenesis-preventing substance in Japanese eel
Development, January 6, 2002; 129(11): 2689 - 2697.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Ikeda, A. Nagai, M.-a. Ikeda, and S. Hayashi
Increased Expression of Mullerian-Inhibiting Substance Correlates with Inhibition of Follicular Growth in the Developing Ovary of Rats Treated with E2 Benzoate
Endocrinology, January 1, 2002; 143(1): 304 - 312.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, T. R. Kumar, M. M. Matzuk, U. M. Rose, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, et al.
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Endocrinology, November 1, 2001; 142(11): 4891 - 4899.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Messika-Zeitoun, L. Gouedard, C. Belville, M. Dutertre, L. Lins, S. Imbeaud, I. A. Hughes, J.-Y. Picard, N. Josso, and N. di Clemente
Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4390 - 4397.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe
Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression
Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Fleming and D. Crews
Estradiol and Incubation Temperature Modulate Regulation of Steroidogenic Factor 1 in the Developing Gonad of the Red-Eared Slider Turtle
Endocrinology, April 1, 2001; 142(4): 1403 - 1411.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Trbovich, P. M. Sluss, V. M. Laurich, F. H. O'Neill, D. T. MacLaughlin, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
PNAS, March 1, 2001; (2001) 51632298.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
S. Nef and L. F. Parada
Hormones in male sexual development
Genes & Dev., December 15, 2000; 14(24): 3075 - 3086.
[Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Teixeira, D. J. Kehas, R. Antun, and P. K. Donahoe
Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells
PNAS, November 23, 1999; 96(24): 13831 - 13838.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al.
Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS
Clin. Cancer Res., November 1, 1999; 5(11): 3488 - 3499.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Teixeira, E. Fynn-Thompson, A. H. Payne, and P. K. Donahoe
Mullerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level
Endocrinology, October 1, 1999; 140(10): 4732 - 4738.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
M. M. Lee, C. C. Seah, P. T. Masiakos, C. M. Sottas, F. I. Preffer, P. K. Donahoe, D. T. MacLaughlin, and M. P. Hardy
Mullerian-Inhibiting Substance Type II Receptor Expression and Function in Purified Rat Leydig Cells
Endocrinology, June 1, 1999; 140(6): 2819 - 2827.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Y. Mishina, D. J. Whitworth, C. Racine, and R. R. Behringer
High Specificity of Mullerian-Inhibiting Substance Signaling in Vivo
Endocrinology, May 1, 1999; 140(5): 2084 - 2088.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
N. K. Arambepola, D. Bunick, and P. S. Cooke
Thyroid Hormone and Follicle-Stimulating Hormone Regulate Mullerian-Inhibiting Substance Messenger Ribonucleic Acid Expression in Cultured Neonatal Rat Sertoli Cells
Endocrinology, November 1, 1998; 139(11): 4489 - 4495.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Gouedard, Y.-G. Chen, L. Thevenet, C. Racine, S. Borie, I. Lamarre, N. Josso, J. Massague, and N. di Clemente
Engagement of Bone Morphogenetic Protein Type IB Receptor and Smad1 Signaling by Anti-Mullerian Hormone and Its Type II Receptor
J. Biol. Chem., September 1, 2000; 275(36): 27973 - 27978.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Trbovich, P. M. Sluss, V. M. Laurich, F. H. O'Neill, D. T. MacLaughlin, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents
PNAS, March 13, 2001; 98(6): 3393 - 3397.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society